Yingxue Huang Xiulian Xu Yi Liu Kan Wu Wei Zhang Pai Liu Xuesi Zeng Jianfang Sun Yiqun Jiang Hongsheng Wang
10.2147/CIA.S36371
Clin Interv Aging
2012;7:533-8.
mycobacterium marinum amikacin clarithromycin nontuberculous mycobacteria skin infection
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/23226012/
Amikacin / therapeutic use Anti-Bacterial Agents / therapeutic use Mycobacterium Infections, Nontuberculous / diagnosis Mycobacterium Infections, Nontuberculous / drug therapy Mycobacterium marinum / genetics
Amikacin / therapeutic use Anti-Bacterial Agents / therapeutic use Mycobacterium Infections, Nontuberculous / diagnosis Mycobacterium Infections, Nontuberculous / drug therapy Mycobacterium marinum / genetics Case Reports Research Support, Non-U.S. Gov't Aged Bacterial Proteins Chaperonin 60 Genotype Humans Male Polymerase Chain Reaction Polymorphism, Restriction Fragment Length RNA, Bacterial RNA, Ribosomal, 16S Anti-Bacterial Agents Bacterial Proteins Chaperonin 60 RNA, Bacterial RNA, Ribosomal, 16S heat-shock protein 65, Mycobacterium Amikacin Infection with Mycobacterium marinum
PMC3514062
23226012
Successful treatment of refractory cutaneous infection caused by Mycobacterium marinum with a combined regimen containing amikacin
2012